查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1417203

酒糟治疗市场报告：2030 年趋势、预测和竞争分析

Rosacea Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

酒糟的治疗趋势和预测

至2030年，全球酒糟治疗市场预计将达到31.6亿美元，2024年至2030年的复合年增长率为7.8%。该市场的主要驱动因素是酒糟发病率和患病率的上升、联合治疗、组合产品的增长趋势以及老年人口数量的增加。全球酒糟治疗市场的未来看起来充满希望，抗生素、α促效剂、类视色素类固醇、免疫抑制剂和抗高血压药物市场充满机会。

酒糟治疗市场洞察

Lucintel 预计 Topics 在预测期内将实现最高成长。

由于消费者知识的扩大、新药的开发以及准确诊断的技术发展，预计北美地区在预测期内将出现最高的增长。

常问问题

Q.1酒糟治疗的市场规模有多大？

A1. 到 2030 年，全球酒糟治疗市场预计将达到 31.6 亿美元。

Q.2酒糟治疗市场的成长预测为何：

A2. 2024年至2030年，全球酒糟治疗市场预计将以7.8%的复合年增长率成长。

Q.3 影响酒糟治疗市场成长的关键因素有哪些：

A3. 该市场的主要驱动力是酒糟发病率和联合治疗的上升、组合产品的增长趋势以及老年人口数量的增加。

Q4.市场的主要细分市场是：

A4.酒糟治疗市场的未来看起来充满希望，抗生素、α促效剂、类视色素A、皮质类固醇、免疫抑制剂和抗高血压药物市场都有机会。

Q5.市场的主要企业是：

A5. 主要的酒糟治疗公司如下。

  • Galderma
  • Allergan
  • Bayer
  • Bausch Health Companie
  • Leo Pharma
  • Sol-Gel Technologies
  • Foamix Pharmaceuticals
  • Aclaris Therapeutics
  • Anaptysbio

Q6.未来最大的细分市场是什么？

A6.Lucintel 预计 Topics 在预测期内将出现最高成长。

Q7. 未来五年预计哪些地区的市场成长最大？

A7. 由于消费者知识的扩展、新药的开发以及准确诊断的技术发展，预计北美在预测期内将经历最高的增长。

Q8. 可以客製化报告吗？

A8. 是的，Lucintel 提供 10% 的客製化服务，无需额外付费。

目录

第一章执行摘要

第二章全球酒糟治疗市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球酒糟治疗市场趋势（2018-2023）和预测（2024-2030）
  • 按药物类别分類的全球酒糟治疗市场
    • 抗生素
    • α促效剂
    • 类视色素A
    • 皮质类固醇
    • 免疫抑制剂
    • 抗高血压
    • 其他的
  • 按管理方法分類的全球酒糟治疗市场
    • 外用
    • 口服

第四章 2018-2030年区域市场趋势及预测分析

  • 全球酒糟治疗市场（按地区）
  • 北美酒糟治疗市场
  • 欧洲酒糟治疗市场
  • 亚太地区酒糟治疗市场
  • 其他地区酒糟治疗市场

第五章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第六章 成长机会与策略分析

  • 成长机会分析
    • 按药物类别分類的全球酒糟治疗市场成长机会
    • 按管理方法分類的全球酒糟治疗市场成长机会
    • 按地区分類的全球酒糟治疗市场成长机会
  • 全球酒糟治疗市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 扩大全球酒糟治疗市场的产能
    • 全球酒糟治疗市场的合併、收购和合资企业
    • 认证和许可

第七章主要企业概况

  • Galderma
  • Allergan
  • Bayer
  • Bausch Health Companie
  • Leo Pharma
  • Sol-Gel Technologies
  • Foamix Pharmaceuticals
  • Aclaris Therapeutics
  • AnaptysBio
简介目录

Rosacea Treatment Trends and Forecast

The future of the global rosacea treatment market looks promising with opportunities in the antibiotics, alpha agonists, retinoids, corticosteroids, immunosuppressants, and antihypertensive agents markets. The global rosacea treatment market is expected to reach an estimated $3.16 billion by 2030 with a CAGR of 7.8% from 2024 to 2030. The major drivers for this market are rising rosacea incidence and prevalence combination therapies, growing the tendency for combination products, and growing number of elderly people.

A more than 150-page report is developed to help in your business decisions.

Rosacea Treatment by Segment

The study includes a forecast for the global rosacea treatment by drug class, mode of administration and region.

Rosacea Treatment Market by Drug Class [Shipment Analysis by Value from 2018 to 2030]:

  • Antibiotics
  • Alpha agonists
  • Retinoids
  • Corticosteroids
  • Immunosuppressants
  • Antihypertensive Agents
  • Others

Rosacea Treatment Market by Mode of Administration [Shipment Analysis by Value from 2018 to 2030]:

  • Topical
  • Oral

Rosacea Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Rosacea Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies rosacea treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the rosacea treatment companies profiled in this report include-

  • Galderma
  • Allergan
  • Bayer
  • Bausch Health Companie
  • Leo Pharma
  • Sol-Gel Technologies
  • Foamix Pharmaceuticals
  • Aclaris Therapeutics
  • Anaptysbio

Galderma, Allergan, Bayer, Bausch Health Companies, Leo Pharma, Sol-Gel Technologies, Foamix Pharmaceuticals, Aclaris Therapeutics, and AnaptysBio are the major suppliers in the rosacea treatment market.

Rosacea Treatment Market Insights

Lucintel forecasts that topical is expected to witness highest growth over the forecast period.

North America is expected to witness highest growth over the forecast period due to expanding consumer knowledge, the creation of new medications, and technical developments for precise diagnosis.

Features of the Global Rosacea Treatment Market

Market Size Estimates: Rosacea treatment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Rosacea treatment market size by drug class, mode of administration, and region in terms of value ($B).

Regional Analysis: Rosacea treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different drug class, mode of administration, and regions for the rosacea treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the rosacea treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the rosacea treatment market size?

Answer: The global rosacea treatment market is expected to reach an estimated $3.16 billion by 2030.

Q.2 What is the growth forecast for rosacea treatment market?

Answer: The global rosacea treatment market is expected to grow with a CAGR of 7.8% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the rosacea treatment market?

Answer: The major drivers for this market are rising rosacea incidence and prevalence combination therapies, growing the tendency for combination products, and growing number of elderly people.

Q4. What are the major segments for rosacea treatment market?

Answer: The future of the rosacea treatment market looks promising with opportunities in the antibiotics, alpha agonists, retinoids, corticosteroids, immunosuppressants, and antihypertensive agents markets.

Q5. Who are the key Rosacea Treatment Market companies?

Answer: Some of the key rosacea treatment companies are as follows.

  • Galderma
  • Allergan
  • Bayer
  • Bausch Health Companie
  • Leo Pharma
  • Sol-Gel Technologies
  • Foamix Pharmaceuticals
  • Aclaris Therapeutics
  • Anaptysbio

Q6. Which rosacea treatment market segment will be the largest in future?

Answer: Lucintel forecasts that topical is expected to witness highest growth over the forecast period.

Q7. In rosacea treatment market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to expanding consumer knowledge, the creation of new medications, and technical developments for precise diagnosis.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the rosacea treatment market by drug class (antibiotics, alpha agonists, retinoids,corticosteroids, immunosuppressants, antihypertensive agents, and others), mode of administration (topical and oral), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Rosacea Treatment Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Rosacea Treatment Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Rosacea Treatment Market by Drug Class
    • 3.3.1: Antibiotics
    • 3.3.2: Alpha agonists
    • 3.3.3: Retinoids
    • 3.3.4: Corticosteroids
    • 3.3.5: Immunosuppressants
    • 3.3.6: Antihypertensive Agents
    • 3.3.7: Others
  • 3.4: Global Rosacea Treatment Market by Mode of Administration
    • 3.4.1: Topical
    • 3.4.2: Oral

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Rosacea Treatment Market by Region
  • 4.2: North American Rosacea Treatment Market
    • 4.2.2: North American Rosacea Treatment Market by Mode of Administration: Topical and Oral
  • 4.3: European Rosacea Treatment Market
    • 4.3.1: European Rosacea Treatment Market by Drug Class : Antibiotics, Alpha agonists, Retinoids, Corticosteroids, Immunosuppressants, Antihypertensive Agents, and Others
    • 4.3.2: European Rosacea Treatment Market by Mode of Administration: Topical and Oral
  • 4.4: APAC Rosacea Treatment Market
    • 4.4.1: APAC Rosacea Treatment Market by Drug Class : Antibiotics, Alpha agonists, Retinoids, Corticosteroids, Immunosuppressants, Antihypertensive Agents, and Others
    • 4.4.2: APAC Rosacea Treatment Market by Mode of Administration: Topical and Oral
  • 4.5: ROW Rosacea Treatment Market
    • 4.5.1: ROW Rosacea Treatment Market by Drug Class: Antibiotics, Alpha agonists, Retinoids,Corticosteroids,Immunosuppressants,Antihypertensive Agents, and Others
    • 4.5.2: ROW Rosacea Treatment Market by Mode of Administration: Topical and Oral

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Rosacea Treatment Market by Drug Class
    • 6.1.2: Growth Opportunities for the Global Rosacea Treatment Market by Mode of Administration
    • 6.1.3: Growth Opportunities for the Global Rosacea Treatment Market by Region
  • 6.2: Emerging Trends in the Global Rosacea Treatment Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Rosacea Treatment Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Rosacea Treatment Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Galderma
  • 7.2: Allergan
  • 7.3: Bayer
  • 7.4: Bausch Health Companie
  • 7.5: Leo Pharma
  • 7.6: Sol-Gel Technologies
  • 7.7: Foamix Pharmaceuticals
  • 7.8: Aclaris Therapeutics
  • 7.9: AnaptysBio